Organigram Global Inc. (OGI)
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
OrganiGram (OGI) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.05 per share a year ago.
OrganiGram (OGI) Reports Q1 Loss, Lags Revenue Estimates
OrganiGram (OGI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.05 per share a year ago.
Organigram: Premium Pivot Signals Further Margin Expansion
Organigram reported solid Q4 earnings, highlighted by achieving a record gross margin and issuing a net revenue guidance implying sustained double-digit organic growth. Quebec's recent vape launch could boost Organigram's Canadian market share, while consumer shift to quality experiences could boost sales of higher-margin liquid diamond vapes. Organigram's expanded capacity and adoption of seed-based cultivation reduce its cost per gram while offering opportunities to increase exports to higher-margin international markets.
OrganiGram (OGI) Reports Q4 Loss, Beats Revenue Estimates
OrganiGram (OGI) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.04 per share a year ago.
Sell Village Farms And Buy Organigram
Organigram upgraded to Buy and Village Farms downgraded to Strong Sell, reflecting shifts in fundamentals and valuation. OGI stands out for its strong balance sheet, strategic partnership with BTI, and potential for margin expansion, despite near-term risks. VFF has surged 356% year-to-date, but concerns over its rapid run-up, lack of guidance, and potential Texas disappointment justify a cautious outlook.
Organigram Global Inc. (OGI) Q3 2025 Earnings Call Transcript
Title: Organigram Global Inc. (NASDAQ:OGI ) Q3 2025 Earnings Call August 13, 2025 8:00 AM ET Company Participants Beena G. Goldenberg - CEO & Director Greg Guyatt - Chief Financial Officer Max Schwartz - Director of Investor Relations Conference Call Participants Aaron Thomas Grey - Alliance Global Partners, Research Division Frederico Yokota Choucair Gomes - ATB Capital Markets Inc., Research Division Operator Good morning.
OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates
OrganiGram (OGI) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.02 per share a year ago.
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)
OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago.
Organigram Global Inc. (OGI) Q2 2025 Earnings Call Transcript
Organigram Global Inc. (NASDAQ:OGI ) Q2 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Max Schwartz - Investor Relations Beena Goldenberg - Chief Executive Officer Greg Guyatt - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Yewon Kang - Canaccord Genuity Operator Good morning. My name is Krista, and I will be your conference operator today.
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
OrganiGram (OGI) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago.
Organigram Is A Small-Cap Bargain
Organigram's stock has declined significantly, but my bullish outlook remains due to strong fundamentals, strategic investments, and potential acquisition by British American Tobacco. The company reported a 17% revenue growth in Q1 FY24, driven by international expansion and the Motif Labs acquisition, despite missing expectations. Organigram's balance sheet is robust with C$46.8 million in cash, no debt, and a healthy current ratio of 3.3X, mitigating many risks.
Organigram Holdings Inc. (OGI) Q1 2025 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ:OGI ) Q1 2025 Earnings Conference Call February 11, 2025 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Greg Guyatt - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Yewon Kang - Canaccord Genuity Operator Good morning. My name is Krista, and I will be your conference operator today.
